Contribution to the Preclinical Safety Assessment of Lannea velutina and Sorindeia juglandifolia Leaves

Dried leaves of A. Rich. and (A. Rich.) Planch. ex Oliv. (family Anacardiaceae) are used in African traditional medicine. Although these medicinal plants have widespread use in the treatment of inflammatory diseases, there is no scientific data concerning their preclinical or clinical safety. This w...

Full description

Saved in:
Bibliographic Details
Published inPlants (Basel) Vol. 12; no. 1; p. 130
Main Authors Malú, Quintino, Lima, Katelene, Malmir, Maryam, Pinto, Rui, da Silva, Isabel Moreira, Catarino, Luís, Duarte, Maria Paula, Serrano, Rita, Rocha, João, Lima, Beatriz Silva, Silva, Olga
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 27.12.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dried leaves of A. Rich. and (A. Rich.) Planch. ex Oliv. (family Anacardiaceae) are used in African traditional medicine. Although these medicinal plants have widespread use in the treatment of inflammatory diseases, there is no scientific data concerning their preclinical or clinical safety. This work aimed to investigate the phytochemical properties of the leaves of both species using HPLC-UV/DAD, as well as the in vivo oral repeated-dose toxicity of 70% hydroethanolic leaf extract of and the in vitro genotoxicity of 70% hydroethanolic leaf extracts of and . Clinical signs of toxicity, body weight variations, and changes in food consumption, mortality, and blood biochemical parameters were monitored. Genotoxicity was assessed using the bacterial reverse mutation assay (Ames test) with and without metabolic activation, according to OECD guidelines. The obtained results showed the presence of gallic acid and anacardic acid as the main marker constituents in both species. No significant changes in general body weight or food intake were observed; small significant changes with no critical relevance were observed in the blood biochemistry of animals treated with hydroethanolic extract (50, 400, and 1000 mg/kg body weight) compared to those in the control group. No genotoxicity was observed in the bacterial reverse mutation assay with and extracts (up to 5 mg/plate). The safety data obtained in vivo and lack of genotoxic potential in vitro points to the safe medicinal use of and extracts.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2223-7747
2223-7747
DOI:10.3390/plants12010130